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Abstract
Background: Right ventricular (RV) dysfunction has been shown to be a major contributor to the adverse outcomes in subjects 
with heart failure. Few studies evaluating the right ventricle in heart failure subjectshave been carried out in Sub-Saharan Africa. 
This studywas therefore designed to evaluate the right ventricular systolic function in subjects with heart failure secondary to 
hypertensive heart disease presenting to the University College Hospital, Ibadan Nigeria.
Methodology: Seventy-six subjects with heart failure secondary to hypertension and 92 normal controls underwent clinical, 
electrocardiographic and echocardiographic evaluation. Indices of  right ventricular systolic function that were measured include 
tricuspid annular plane systolic excursion (TAPSE), tissue Doppler derived tricuspid peak systolic lateral annulus velocity(S') and 
right ventricular fractional areachange(RVFAC).
Results: Sixty-two (81.6%) heart failure subjects had right ventricular systolic dysfunction, 31(40.8%) had abnormal TAPSE, 
42(55.5%) had abnormal S' while 49(64.5%) had abnormal RVFAC. Elevated pulmonary artery systolic pressure was found in 
25(32.9%) of  the subjects. There was no relationship between the indices of  right ventricular systolic function and the estimated 
systolic pulmonary artery pressures. The independent predictor of  right ventricular systolic dysfunction was the right atrial size.
Conclusion: Right ventricular systolic function is impaired in patients with heart failure secondary to hypertensive heart disease. 
There is no relationship between the indices of  right ventricular systolic function and systolic pulmonary artery pressure. Further 
studies are needed to assess right ventricular systolic function in Nigerians.
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Introduction
Heart failure (HF) is a major and growing public health 
problem around the world with a prevalence of  more 
than 23 million worldwide.1 Despite the advances in the 
prevention and management of  cardiovascular diseas-
es, mortality in heart failure is still high. Therefore, the 
identification of  the predictors of  mortality in heart fail-
ure has been an area of  extensive research. A number 
of  studies have provided evidence that right ventricular 
systolicfunction is an independent prognostic factor in 
moderate to severe heart failure.2– 4
Pulmonary hypertension is considered an important con-
tributor toexercise intolerance in heart failure.5,6 and sev-
eral studies have reported an inverse relationship between 
right ventricular systolic function and pulmonary hyper-
tension.7
Although there are newer and more advanced methods 
of  assessing right ventricular systolic function, echocardi-
ography has been reported to be equally clinically useful8, 
9 and still remains an attractive tool because of  its obvious 
advantages of  non-invasiveness, low cost and easy repro-
ducibility.
Amongst the various indices of  RV systolic function that 
can beevaluated using echocardiography, more studies ha-
vedemonstrated the clinical utility and value of  TAPSE, 
2D RV FAC,and S' of  the tricuspid annulus.10–13 RV FAC 
has been shown to correlate with RVEF by magnetic 
resonance imaging (MRI).11,14 TAPSE has been shown 
to correlate strongly with radionuclide angiographic as-
sessment of  right ventricular function.10 S' has also been 
found to strongly correlate with right ventricular ejection 
fraction obtained by radionuclide angiography.15
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Most of  the studies on right ventricular systolic function 
in heart failure were carried out in Caucasians with very 
few studies on indigenous Africans. Heart failure in Af-
rica is mostly attributed to non-ischaemic factors such as 
hypertension, valve disorders, idiopathic cardiomyopathy 
in contrast to western countries where ischaemic heart 
disease is a major contributor to the aetiology of  heart 
failure.16 Studies across sub-Saharan Africa have doc-
umented hypertension as the commonest aetiology of  
heart failure in Africans.17 Local studies done in Nigeria 
have also reported hypertension as the commonest aeti-
ology of  heart failure in Nigerians.18–20
This study therefore aimed to evaluate the right ventricu-
lar systolic function in subjects with heart failure second-
ary to hypertensive heart disease and to determine the 
relation- ship between right ventricular systolic function 
and estimated systolic pulmonary artery pressure.
Methodology
This study was carried out at the University College Hos-
pital, Ibadan, Nigeria. The study protocol was approved 
by the ethics committee of  the hospital and each partici-
pant signed an informed consent form in accordance with 
the Declaration of  Helsinki. The study was cross-section-
al in design. The study was powered at 90% to detect a 
mean difference of  2.5mm in the tricuspid annular plane 
systolic excursion between subjects with heart failure and 
normal controls.
Seventy-six patients with heart failure secondary to hyper-
tensive heartdisease and ninety- two apparently healthy 
controls were recruited consecutively. The exclusion cri-
teria among subjects with heart failure included those 
with heart failure due to aetiology other than hyperten-
sioneven if  co-existing with hypertension, co-morbidities 
such as ischaemic heart disease/myocardial infarction, 
diabetes mellitus, thyroid disease, chronickidney disease, 
anaemia, asthma and chronic obstructive pulmonary dis-
ease (COPD). Other exclusion criteria among subjects 
and controls included pregnancy, current smokers, sig-
nificant alcohol use of  more than 14 units perweek for 
women and 21 units per week for men, gout, poor echo-
cardiographic window and refusal to give consent.
 
Echo-cardiographic Studies
Trans-thoracic echocardiography was performed using a 
Toshiba Xario™ cardiac ultrasound system on all subjects 
and controls in the left lateral decubitus position and mea-
surements were taken according to the recommendations 
of  the American Society of  Echocardiography.21 Measures 
of  right ventricular systolic function evaluated included 
tricuspid annular plane systolic excursion (TAPSE) which 
was acquired by placing an M-mode cursor through the 
tricuspid annulus, in the apical four-chamber view, and 
measuring the amount of  longitudinal excursion of  the 
annulus at peak systole; tissue Doppler derived tricuspid 
peak systolic lateral annulus velocity (S' ) was obtained 
from apical 4-chamber window with thepulsed Doppler 
sample volume placed on the lateral tricuspid annulus.
Systolic pulmonary artery pressure (SPAP) was estimat-
ed by measuring the maximum velocity of  the tricuspid 
regurgitant jet. In the absence of  a gradient across the 
pulmonary valve, SPAP is equal to the right ventricular 
systolic pressure (RVSP). RVSP was derived from the 
tricuspid valve regurgitant jet velocity, using the simpli-
fied Bernoulli equation and combining this value with an 
estimate of  the right atrial(RA) pressure: RVSP = 4(V)2 
+ RA pressure. Where V is the peak velocity (in meters 
per second) of  the tricuspid valve regurgitant jet,and RA 
pressure was estimated from IVC diameter and respi-
ratory changes. Inferior Vena Cava (IVC) diameter less 
than or equal to 2.1 cm that collapses greater than 50% 
with a sniff  suggests a normal RA pressure of  3mm Hg 
(range,0-5 mm Hg), whereas an IVC diameter greater 
than 2.1 cm that collapses lessthan 50% with a sniff  sug-
gests a high RA pressure of  15 mm Hg (range, 10-20 
mmHg). Normal resting values for SPAP values are usu-
ally defined as a peak TR gradient of  2.8 to 2.9 m/s or a 
peak systolic pressure of  35 or 36mm Hg, assuming an 
RA pressure of  3 to 5mm Hg.22
 
Data management and analysis
Data was analysed using R statistical software version 
3.3.2.23 For quantitative data, the mean ± standard devi-
ation or the median ± median absolute deviation – for 
non-normally distributed data were reported for descrip-
tive purposes while frequencies(percentages) were re-
ported for qualitative data. The Shappiro-Wilk’s test was 
used to test for normality. Student’s ’t’ test, or the Mann 
Whitney’s test (non-parametric testing for non-normalda-
ta) were used to test for the differences in the continuous 
variables between the two groups while chi-squared anal-
ysis was used to test for the differences in the categoric 
variables betweenthe groups. Pearson’s correlation was 
used to evaluate the bivariate relationship between the 
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parameters of  RV systolic function and some clinical and 
echocardiographic indices. A stepwise logistic regression 
model was used to determine the independent correlates 
of  RV systolic dysfunction. A two-tailed p-value of  < 
0.05 was considered significant.
Results
A total of  168 subjects (76 patients with heart failure and 
92 controls) were recruited consecutively for the study 
over a 6 month period. Table 1 compares the baseline 
characteristics of  the subjects with heart failure and the 
controls. The subjects with heart failure were older and 
had higher pulse rate when compared with the controls. 
Table 2 shows the echocardiographic parameters and fre-
quencies of  abnormal RV parameters in the subjects. 
Table 1: Baseline characteristics of the subjects 
 
  
Variable Subjects Control P-value† 









Body Mass Index (kg.m−2)‡ 24.9±4.768 25.3±4.44 0.2327 
Pulse (/min) 88.2±12.97 70.5±10.1 0.0000* 
Systolic Blood Pressure (mmHg)‡ 116.0±20.76 120.0±14.8 0.5063 
Diastolic Blood Pressure (mmHg)‡ 79.0±13.34 80.0±6.67 0.3146 
Pulse Pressure (mmHg)‡ 40.0±14.83 40.0±10.4 0.0528 
Mean Arterial Pressure (mmHg)‡ 90.0±14.83 91.0±8.40 0.7424 
* statistically significant, 
‡ median±median absolute deviation and Mann Whitney test 
† Student ‘t’ test 
TAPSE Tricuspid annular plane systolic excursion, S' TDI Lateral Tricuspid Annular Systolic Velocity, RVFAC Right Ventricular 
Fractional Area Change, RVD Right Ventricular Internal Diameter
Figure 1: Relationship between RV function parameters and number of  abnormal RV function indices
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The limits of  normal values for the indices of  right ven-
tricular systolic function were generated from the 2.5 per-
centile of  the values obtained in the normal controls. The 
values generated were: TAPSE - 17.1 mm, S' - 10.3cm/s, 
RV FAC - 23.6%. Subjects were deemed to have right 
ventricular (RV) systolic dysfunction if  they had values 
inany of  the RV systolic function parameters below the 
generated cut-offpoints. The prevalence of  right ven-
tricular (RV) systolic dysfunction among the subjects 
with heart failure was 81.6%. TAPSE was abnormal in 
31(40.8%) of  the subjects, S' was abnormal in 42(55.8%) 
of  the subjects while RVFAC was abnormal in 49(64.5%) 
of  the subjects. Furthermore, 19(25.0%), 26(34.2%), and 
17(22.4%) of  the subjects had one, two and three RV sys-
tolic function parameters abnormal respectively. Figure 1 
shows the relationship between RV function parameters 
and the number of  abnormal RV function indices among 
the subjects.
The estimated right ventricular systolic pressure (RVSP) 
and hencethe systolic pulmonary artery pressure (SPAP) 
ranged from 10.2mmHg to 84.7mmHg. The mean value 
was 29(14.6) mmHg. Using a cut-off  value of  35mmHg, 
25 (32.9%) of  the patients had pulmonary hypertension. 
Table 3 compares clinical and echocardiographic indices 
in the subject with hypertensive heart failure and pulmo-
nary hypertension and those without pulmonary hyper-
tension. The major difference between the two groups 
was theincreased right atrial dimensions in the hyperten-
sive heart failure subjects with pulmonary hypertension 
when compared with those without pulmonary hyperten-
sion.
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Left Atrial Diameter (cm) 4.65±0.667 3.21±0.44 0.0000*
Inter-ventricular Septal thickness – Diastole (cm) 0.93±0.208 0.85±0.15 0.0011*
LV Posterior wall thickness – Diastole (cm) 0.94±0.200 0.85±0.15 0.0000*
LV Internal Diameter – Diastole (cm) 6.44±0.875 4.60±0.59 0.0000*
LV Internal Diameter – Systole (cm)‡ 5.44±0.963 2.87±0.53 0.0000*
LV Fractional Shortening (%) 15.2±6.598 35.9±6.40 0.0000*
LV Ejection Fraction (%) 31.1±11.62 65.8±8.90 0.0000*
Right Atrial Diameter – major axis (cm) 6.19±1.060 4.70±0.49 0.0000*
Right Atrial Diameter – minor axis (cm) 4.70±0.652 3.71±0.43 0.0000*
Right Ventricular Internal Diameter (cm) 3.08±0.645 2.30±0.30 0.0000*
Right Ventricular Fractional Area Change (%) ‡ 21.2±8.041 35.2±5.58 0.0000*
Tricuspid Regurgitant Velocity (mm.s−1)) 196.3±100.10 0.00±0.00 0.0000*
Right Ventricular Systolic Pressure (mmHg) 25.0±15.17 0.00±0.00 0.0000*
Right ventricular outflow tract velocity (m.s−1) 0.58±0.141 0.67±0.15 0.0026*
Tricuspid Annular Plane Systolic Excursion (mm)‡ 17.9±4.72 22.2±2.97 0.0000*
Lateral Tricuspid Annular Systolic Velocity (mm.s−1)‡ 10.1±1.82 13.1±1.93 0.0000*






LV: Left Ventricle, *:statistical significance
†: values are median ±median absolute deviation and Mann-Whitney test except when stated
‡:means±sd and Student ’t’ test, †† : X2 analysis
Table 4 shows the correlation of  the parameters of  RV 
systolic function withsome clinical and echocardiographic 
variables. TAPSE correlated with the LV ejection fraction 
and negatively correlated with right atrial diameter and 
RV internal diameter while S' had negative correlations 
with right atrial diameter and RV internal diameter. RV-
FAC had positive correlation with LV ejection fraction 
and negative correlation with LV internal diameter.
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Age (years)‡ 55.0±14.83 60.0±11.86 0.6621
Body Mass Index (kg.m−2)‡ 24.2±3.89 25.0±5.21 0.6072
Pulse (/min)‡ 91.0±7.41 90.0±14.83 0.6818
Systolic Blood Pressure (mmHg) 122.6±23.59 116.7±20.44 0.2639
Diastolic Blood Pressure (mmHg)‡ 80.0±14.83 74.0±8.90 0.1368
Mean Arterial Pressure (mmHg) 96.6±17.73 90.1±13.89 0.0879
Left Atrial Diameter (cm) 4.73±0.595 4.64±0.782 0.6325
Inter-ventricular Septal thickness – Diastole (cm) 1.00±0.223 0.93±0.203 0.1518
LV Posterior wall thickness – Diastole (cm)‡ 1.00±0.237 0.94±0.193 0.1805
LV Internal Diameter – Diastole (cm)‡ 6.35±0.815 6.60±0.934 0.6305
LV Internal Diameter – Systole (cm) 5.38±0.900 5.47±1.000 0.7106
LV Fractional Shortening (%)‡ 15.0±7.41 15.3±5.97 0.5615
LV Ejection Fraction (%)‡ 31.0±13.74 31.3±10.97 0.7152
Right Atrial Diameter – major axis (cm) 6.66±1.020 5.94±1.102 0.0074*
Right Atrial Diameter – minor axis (cm)‡ 4.97±0.400 4.53±0.697 0.0072*
Right Ventricular Internal Diameter (cm) 3.18±0.533 2.96±0.742 0.1907
Right Ventricular Fractional Area Change (%)‡ 20.6±8.45 18.5±7.77 0.4292
Tricuspid Regurgitant Velocity (mm.s−1)) 294.5±48.28 144.0±66.41 0.0000*
Right Ventricular Systolic Pressure (mmHg)‡ 44.4±9.04 19.4±7.56 0.0000*
Right ventricular outflow tract velocity (m.s−1)‡ 0.58±0.163 0.59±0.148 0.9207
Tricuspid Annular Plane Systolic Excursion (mm) 17.9±6.39 17.9±3.73 0.9847
Lateral Tricuspid Annular Systolic Velocity (mm.s−1) 10.4±1.52 9.90±1.947 0.2741
LV: Left Ventricle, * statistical significance, † Student ‘t’ test, ‡ median±median absolute deviation with Mann Whitney test
A stepwise logistic model was evaluated to determine 
the independent correlates of  RV systolic dysfunction 
among subjects with heart failure. The explanatory vari-
ables included in the model were the age and gender of  
the subjects, body mass index, DBP, left atrial diameter, 
left ventricular internal diameter, LV ejection fraction, 
RV internal diameter, right atrial major-axis diameter and 
RV outflow tract velocity. The only determinant of  RV 
systolic function in this study is the right atrial dimension. 
(Table 5).
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Table 4: Correlation of RV systolic function parameters with Clinical and Echocardiographic Parameters
Variable TAPSE S' RVFAC
r p-value r p-value r p-value
Body Mass Index 0.202 0.0808 0.036 0.7565 0.213 0.0644
Left Atrial Diameter -0.162 0.1612 -0.081 0.4861 -0.086 0.4584
LV Ejection Fraction 0.293 0.0102* 0.158 0.1720 0.341 0.0026*
LV Internal Diameter – Diastole -0.109 0.3493 -0.151 0.1933 -0.218 0.0583
LV Internal Diameter – Systole -0.196 0.0903 -0.110 0.3438 -0.321 0.0047*
LV Mass Index 0.127 0.2755 0.190 0.1000 0.014 0.9048
Right Atrial Diameter – major axis -0.338 0.0028* -0.297 0.0093* -0.100 0.3901
Right Ventricular Internal Diameter -0.316 0.0054* -0.329 0.0037* -0.169 0.1446
Right Ventricular Systolic Pressure -0.034 0.7690 0.074 0.5252 -0.053 0.6494
Tricuspid Annular Plane Systolic Excursion 0.485 0.0000* 0.354 0.0017*
Lateral Tricuspid Annular Systolic Velocity 0.328 0.0039*
LV: Left Ventricle, *statistical significance
TAPSE: Tricuspid Annular Plane Systolic , S': Tissue Doppler derived Tricuspid Peak Systolic Lateral 
Annulus Velocity, RVFAC: Right Ventricular Fractional Area Change, r: Pearson Correlation Coefficient.
Table 5: Independent Relations of RV Systolic Dysfunction in the Subjects
Odds Ratio p-value 95% Conf. Intervals
Right Ventricular Outflow Tract Velocity 0.13 0.3942 0.001– 0.698
Right Atrial Diameter – major axis 3.11 0.0060 1.477 – 7.663
Left ventricular ejection fraction 0.94 0.0715 0.867 – 1.003
p-value = 0.0045, Nalgelkerke R2 = 0.486, *statistical significance
Discussion
In this study, about 80% of  our subjects with heart failure 
secondary to hypertensive heart disease have impaired 
RV systolic function. Also,  about one-third of  subjects 
with hypertensive heart disease in this study had elevated 
pulmonary artery pressure which however, had no signifi-
cant association with RV systolic dysfunction in the study 
population. The LV ejection fraction, right atrial and RV 
dimensions are associated with parameters of  RV systolic 
function while right atrial dimension is the only indepen-
dent correlate of  RV systolic dysfunction in this group of  
subjects with hypertensive heart failure.
The finding of  high prevalence of  RV systolic dysfunc-
tion in heartfailure seen in this study supports finding 
from other studies that had documented varying preva-
lence of  RV systolic dysfunction in subjects with heart 
failure. Puwanant and his colleagues24 studied right ven-
tricular systolic function in subjects with heart failure us-
ing RV FAC, S' and TAPSE. However, the study group 
was heterogenous with respect to the aetiology of  heart 
failure: 51% had coronary artery disease, 37% had diabe-
tes and 32.5% had cardiomyopathies. The subjects were 
grouped into heart failure with preserved ejection fraction 
(HFPEF) and heart failure with reduced ejection fraction 
(HFREF). They reported a finding of  a prevalence of  
40%, 50%, 33% for TAPSE, S' and RV  FAC  respectively 
in those with HFPEF and  76%,  73%,  63% in those with 
HFREF. In comparison with this study in which 89.5% 
of  the subjects with heart failure had HFREF, the study 
of  Puwanant et al.24 had a much higher prevalence of  
abnormal TAPSE and S' for the subjects with HFREF. 
The prevalence of  abnormal RVFAC was comparable in-
both studies. The marked difference in the prevalence of  
abnormal TAPSE and S' may be accounted for by the 
difference in the aetiology of  heart failure between the 
subjects in the two studies. Coronary artery disease caus-
es regional wall abnormalities which may affect indices of  
right ventricular systolic function like TAPSE and S'13 to 
a greater extent than RV FAC. Hypertension is likely to 
affect RV FAC more than TAPSE and S' because of  ven-
tricular interdependence.25 In actual fact, the prevalence 
of  abnormal RVFAC was slightly higher in this study 
than in the study of  Puwanant et al.24
Ojji and his colleagues4 in a prospective study of  611 
subjects with hypertensive heart failure found RV systolic 
dysfunction – by TAPSE – in 44.5% of  his subjects. This 
is comparable with the prevalence of  abnormal TAPSE 
of  40.8% obtained in our study despite a higher cut-off  
point – 17.1mm versus 15mm – used in our study.
Abnormal RV systolic function has been shown to be a 
major adverse factor in the prognosis of  heart failure26–28. 
Thus, there is a need for increased emphasis on the eval-
uation of  the right heart in heart failure and more efforts 
at investigation of  therapies directed at the right heart.
Our study found no relationship between the indices of  
right ventricular systolic function and estimated pulmo-
nary artery systolic pressure. There is conflicting data 
on the pulmonary vasculature haemodynamics in hy-
pertension. Fiorentini and his colleagues had observed 
that pulmonary vascular resistance rises in parallel with 
peripheral vascular resistance due to the "concept that 
the vasomotility of  the greater and lesser circulation in 
hypertension is disturbed by the same type of  disorder".29 
On the other hand, Fagard et al.30 reported that that there 
is neither a primary nor a secondary effect of  systemic 
hypertension on the pulmonary vasculature in patients 
with World Health Organization stages I to II essential 
hypertension. Kjaergaard et al.31 in their study on right 
ventricular function in heart failure using TAPSE also 
reported that there was no association between systolic 
pulmonary artery pressure and TAPSE. Karaye and col-
leagues32 in their study on hypertensive subjects – without 
heart failure also observed that pulmonary artery systolic 
pressure (PASP) was a correlate of  TAPSE while S' had 
no relationship with PASP. Ghio and colleagues33, in their 
prognostic study of  right ventricular systolic function and 
pulmonary artery pressure(PAP) in patients with chronic 
heart failure, found an inverse relationship between pul-
monary artery pressure (PAP) and RV ejection fraction in 
heart failure. However, they also observed subjects with 
preserved RV function despite elevated PAP and other 
subjects with abnormal RV function and normal PAP 
They reported that their data demonstrated that RV func-
tion may be preserved despite elevated PAP and that RV 
dysfunction may be observed even in patients with nor-
mal PAP. They also noted that the inverse relationship be-
tween PAP and RV dysfunction was seen in the patients 
with RV dysfunction resulting from RV after-load mis-
match such as in dilated and ischaemic cardiomyopathy.
 
Since the mechanism of  right ventricular dysfunction in-
hypertension results more from ventricular interdepen-
dence thanchanges in the pulmonary vasculature,30 this 
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may explain why in this study, there was a failure to ob-
serve the inverse relationship between PASP and the indi-
ces of  right ventricular systolic function, which has been 
documented in heart failure.
Another explanation for the failure of  this study to 
demonstrate any relationship between PASP and RV sys-
tolic function is that over diuresis has been documented 
to reduce pulmonary artery systolic pressure8; some of  
the recruited patients had chronic heart failure and had 
been on long term diuretic therapy.
In univariate analyses, the relations of  TAPSE found in 
our study were LV ejection fraction, right atrial diame-
ter and RV internal diameter. This is similar to findings 
from other studies4,31 in which TAPSE was found to be 
signicantly related to the LV ejection fraction. The effect 
of  LV ejection fraction on right ventricular function had 
been attributed to the effects of  ventricular interdepen-
dence.25,34 In our study, only the right atrial dimension was 
the independent correlate of  RV systolic function our 
subjects. Ojji and colleagues4 had noted the significant as-
sociations of  right atrial size and LV ejection fraction as 
independent correlates of  TAPSE in their study. Howev-
er in our study, LV ejection fraction had no independent 
relationship with RV systolic dysfunction. This could be 
due to our use of  composite values of  TAPSE, S' and 
RVFAC as our measure of  RV systolic dysfunction while 
Ojjiand colleagues only used TAPSE to define RV systol-
ic dysfunction. The contribution of  right atrial function 
to heart failure wasinvestigated by Ojahi Haghighi and 
colleagues35. They suggested that diminished right atrial 
function might play critical role in the pathophysiologi-
cal process of  heart failure patients. Further studies on 
the role of  the right atrium in the heart failure process 
areneeded.
Several studies had attempted to validate echocardio-
graphic parameters of  RV function using cardiac magnet-
ic resonance imaging(CMRI) as gold standard.11,36,37 
These echocardiographic parameters correlated signifi-
cantly with CMRI derived RV ejection fraction. The sen-
sitivity and specificities of  the parameters were TAPSE 
(83.4%, 70.0%),S'(100%,
66%) and RV FAC (40%,80%). The authors suggested 
that TAPSE and S' provided better accuracy than RV 
FAC in subjects with pulmonary hypertension.37
Our study generated the cut-off  points for the parame-
ters of  right ventricular function from the values of  the 
control subjects. These values are comparable to the lim-
its of  RV function parameters guidelines of  the American 
Society of  Echocardiography13 apart from the RVFAC. 
Our cut-off  limits compared with the ASE guidelines are 
TAPSE – 17.1mm versus 16mm, S' 10.3cm/s versus10 
cm/s and RVFAC 23.6% versus 35%. The ASE limits 
were generated mostly from normal Caucasians. Howev-
er, few normative studies have been carried out among 
African subjects. The marked difference in the cut-off  
points for RVFAC indicate that studies to define the lim-
its of  normal RV function parameters in indigenous Af-
ricans are needed.
Although our study subjects were heart failure patients 
secondary to hypertension with the exclusion of  other 
causes of  heart failure, the contribution of  subclinical 
coronary artery disease to the heart failure could have 
been missed as coronary artery disease was excluded 
largely on clinical and electrocardiographic grounds alone 




Right ventricular systolic dysfunction is present in about 
80% of  Nigerians with heart failure secondary to hy-
pertensive heart disease. It is therefore important that 
the assessment of  RV function should form partof  the 
echocardiographic assessment of  subjects with heart fail-
ure. Though pulmonary arterial hypertension is found in 
about a third of  our subjects, it had no relationship with 
the degree of  right ventricular dysfunction. The contri-
bution of  right atrial function to the pathophysiology 
and prognosis ofheart failure is an area that needs further 
clarification.
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